REBIF 44 MCG / 0.5 ML
INTERFERON BETA-1A : 44 MCG / 0.5 ML · DIN 02237320 · EMD SERONO, A DIVISION OF EMD INC., CANADA
Health Canada status: MARKETED
What is REBIF?
REBIF 44 MCG / 0.5 ML contains INTERFERON BETA-1A : 44 MCG / 0.5 ML. It is listed in the Health Canada Drug Product Database under DIN 02237320, held by EMD SERONO, A DIVISION OF EMD INC., CANADA, supplied as SOLUTION for SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 24-Feb-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02237320 |
|---|---|
| Brand name | REBIF |
| Generic / active ingredient | INTERFERON BETA-1A : 44 MCG / 0.5 ML |
| Manufacturer | EMD SERONO, A DIVISION OF EMD INC., CANADA |
| Strength | 44 MCG / 0.5 ML |
| Dosage form | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Schedule | Prescription |
| ATC code | L03AB07 INTERFERON BETA-1A |
| AHFS class | 92:20.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 24-Feb-1998 |
| Original market date | 1998-02-24 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02237320 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2237320 |
| Brand name | REBIF |
| Active ingredient / INN | INTERFERON BETA-1A : 44 MCG / 0.5 ML |
| ATC code | L03AB07 |
| ATC anatomical main group | L — Antineoplastic and immunomodulating agents |
| ATC therapeutic subgroup | L03 |
| AHFS class | 92:20.00 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | EMD SERONO, A DIVISION OF EMD INC., CANADA |
Which pack is which?
| Strength on the label | 44 MCG / 0.5 ML |
|---|---|
| Dosage form | SOLUTION |
| Route | SUBCUTANEOUS |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
What can be used instead?
Other Canadian products sharing ATC code L03AB07 INTERFERON BETA-1A. 5 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AVONEX | 30 MCG / 0.5 ML | SOLUTION | BIOGEN CANADA INC | MARKETED | DIN 02269201 |
| REBIF | 132 MCG / 1.5 ML | SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | MARKETED | DIN 02318261 |
| REBIF | 22 MCG / 0.5 ML | SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | MARKETED | DIN 02237319 |
| REBIF | 66 MCG / 1.5 ML | SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | MARKETED | DIN 02318253 |
| AVONEX | 1.1 ML | POWDER FOR SOLUTION | BIOGEN CANADA INC | CANCELLED POST MARKET | DIN 02237770 |
| AVONEX | 60 MCG | POWDER FOR SOLUTION | BIOGEN CANADA INC | APPROVED | DIN 02267594 |
| REBIF | 132 MCG / 1.5 ML | SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | CANCELLED PRE MARKET | DIN 02318288 |
| REBIF | 2 ML | LIQUID ; KIT ; POWDER | EMD SERONO, A DIVISION OF EMD INC., CANADA | CANCELLED POST MARKET | DIN 02237317 |
| REBIF | 8.8 MCG / 0.2 ML | POWDER FOR SOLUTION ; KIT ; LIQUID | EMD SERONO, A DIVISION OF EMD INC., CANADA | CANCELLED POST MARKET | DIN 02281708 |
| REBIF | 8.8 MCG / 0.2 ML | SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | CANCELLED POST MARKET | DIN 02277492 |
Who else supplies INTERFERON BETA-1A worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. INTERFERON BETA-1A appears in 84 registered pack listings across 12 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.